AllianceBernstein
ANAC

AllianceBernstein’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

AllianceBernstein’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-661,534
Closed -$35.4M – 3086
2016
Q1 		$35.4M Sell
661,534
-110,598
-14% -$8.16M 0.03% 518
2015
Q4 		$87.2M Buy
772,132
+41,836
+6% +$4.61M 0.07% 289
2015
Q3 		$86M Buy
730,296
+629,106
+622% +$82.2M 0.07% 281
2015
Q2 		$7.83M Buy
101,190
+24,600
+32% +$1.61M 0.01% 949
2015
Q1 		$4.43M Buy
76,590
+30,740
+67% +$1.31M ﹤0.01% 1173
2014
Q4 		$1.48M Buy
45,850
+3,250
+8% +$97.6K ﹤0.01% 1949
2014
Q3 		$1.04M Buy
42,600
+1,000
+2% +$20.3K ﹤0.01% 2175
2014
Q2 		$738K Buy
41,600
+3,288
+9% +$52.9K ﹤0.01% 2400
2014
Q1 		$767K Buy
38,312
+1,400
+4% +$27.1K ﹤0.01% 2288
2013
Q4 		$619K Sell
36,912
-5,700
-13% -$78.9K ﹤0.01% 2354
2013
Q3 		$453K Buy
42,612
+673
+2% +$5.89K ﹤0.01% 2524
2013
Q2 		$234K Buy
+41,939
New +$254K ﹤0.01% 2803

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

AllianceBernstein's ANAC Position: Q2 2016 in Review

AllianceBernstein sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 661,534 shares — an estimated $35.4M sold.

AllianceBernstein first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $87.2M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • AllianceBernstein reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • AllianceBernstein sold 661,534 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $35.4M.
  • AllianceBernstein first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • AllianceBernstein's ANACOR PHARMACEUTICALS INC COM position peaked at $87.2M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on AllianceBernstein's 13F filing for Q2 2016, filed 11 Aug 2016.